Background. Primary care should be the place for the early detection of mild cognitive impairment (MCI) and dementia; however, a considerable proportion of these processes remain undetected at this setting. Family doctors may not have enough time or expertise for cognitive testing. The utility of clinical variables, other than cognitive tests, has hardly been investigated. Objectives. To explore the diagnostic and prognostic value of the variables that are usually collected in the medical history of patients with suspected cognitive impairment.
Introduction
Primary care is the most adequate setting for the early detection of cognitive deterioration; 1 however, 50% of the existing dementias are unrecognized at this place. [1] [2] [3] Primary care physicians (PCP) have expressed concerns on their own resources and capacity for the early detection of dementia, particularly as regards the distinction between normal aging and the initial symptoms of dementia. 4, 5 Mild cognitive impairment (MCI) is defined as a transitional zone between normal cognitive aging and dementia. While still in dispute, this entity is largely utilized to identify patients at risk of future dementia. 6, 7 In fact, a recent meta-analysis reported an annual rate of dementia conversion of 5-10% 8 (versus 1-2% conversion rate in subjects without MCI). 9 However, >50% of patients with MCI did not develop dementia after 10 years of follow-up 8 and even some patients reverted to normal cognition. 10 The distinction between patients with MCI who will develop dementia and those who will not is an issue of enormous significance for care and research.
The detection of cognitive deterioration in primary care has traditionally relied on cognitive testing. In this regard, the Mini-Mental State Test (MMS) is the most widely used instrument; 11, 12 however, this test is time-consuming and its sensibility for MCI is low. 6 Shorter cognitive instruments have been investigated, but their efficiency for the detection of MCI remains far from satisfactory. 12 The first signs of dementia may be multiple and varied, including cognitive, affective, behavioural and other manifestations. Conversely, many non-dementing processes (e.g. stress, medical diseases) may provoke cognitive manifestations. Surprisingly, a systematic investigation of the many variables that are usually collected in a first approach to the patient with cognitive manifestations is lacking. These routine variables, regarding onset, source of symptoms, symptom profile, duration, co-morbidity and other, are in most cases related to the cause of cognitive manifestations and could therefore influence cognitive diagnosis and evolution.
In this cohort study, patients displaying cognitive complaints or suspected of having cognitive deterioration were prospectively recruited by PCP during their usual practice. This article will describe the detection rates of MCI and dementia and the clinical features accompanying these diagnoses. In addition, a possible role of clinical variables in the detection and prognosis of MCI and dementia will be explored.
Methods
The study recruitment run from 1 April 2000 to 31 October 2002. The seven PCP (PT, EA, AS, NM, GM, DC and CB) of a public health centre recruited the patients. This centre served San Diego neighbourhood, a low-middle class area in the southern suburbs of the city of Madrid. At the end of the study, the number of people >50 years of age who were registered as potential care-receivers of the participating PCP was 4196; of these people, 2443 (58.2%) were >65 years of age.
Inclusion criteria
The patients were recruited prospectively by PCP during their usual practice, according to the following inclusion criteria: (i) patients >50 years of age; (ii) any complaint or suspicion related to cognition, cognitionrelated functions (i.e. performance of activities of daily living) or behaviour, of unknown aetiology; (iii) complaint or suspicion was raised by the patient, an informant or the PCP and (iv) patient and informant (when available) gave verbal informed consent to participate in the study.
Patients consulting by their own were requested to come accompanied by an informant. All the patients were systematically included, even if the complaints were not considered of clinical relevance by the PCP. Patients just commenting on their bad memory were not included unless they expressed concern or raised their comment as a medical consultation, i.e. looking for answer, explanation or relief. Patients who complained, or for whom cognitive deterioration was suspected, before the recruiting period were included, provided that they had never been studied by specialist. Isolated affective symptoms, i.e. not accompanied by cognitive dysfunction, did not qualify for inclusion.
Clinical variables
Age, sex, level of education, medical and psychiatric co-morbidity, current medications, family history of dementia, kind and number of complaints, as well as onset and source and duration of complaints, were systematically registered. Cognitive and cognition-related manifestations were classified into the following domains: recent memory, remote memory, language, attention/executive functions, visuospatial domain, affective domain and behaviour (e.g. apathy).
Screening instruments and neuropsychological battery
The PCP also administered the Mini-Mental State Test (MMS), 11 the Functional Activities Questionnaire (FAQ) 13 and the Informant-based Questionnaire on Cognitive Decline in the Elderly (IQCODE) 14 (data of FAQ and IQCODE will not be presented in this paper). A few days after detection, a trained psychologist (IC) administered a 30-minute neuropsychological battery encompassing tests of orientation, verbal learning, language, processing speed and construction ability (for a detailed description of the screening instruments and neuropsychological battery, see Appendix 1 in the supplementary data on the journal website http://www.fampra.oupjournlas.org/).
Cognitive and aetiological diagnoses
A senior neurologist with special dedication to behavioural neurology (JO) visited the patient and informant, performed neurological and mental state exam and, after reviewing all the available information (except the screening instruments), established a cognitive, a psychiatric and an aetiological diagnosis. The psychiatric diagnosis was made according to the 4th edition, text revised, of the Diagnostic and Statistical Manual of Mental Disorders. 15 For the cognitive diagnosis, the following study categories were applied: a) No cognitive impairment (NCI). All neuropsychological tests were >10°percentile of published norms for similar age and education group. b) Non-relevant cognitive dysfunction. Some tests were <10°percentile, but it was not deemed to be due to genuine cognitive deterioration but to low pre-morbid level, low education, lack of motivation or sensory defect. c) MCI. Performance fell <10°percentile in at least one neuropsychological test; it was deemed of clinical relevance, but dementia criteria were not fulfilled. 15 d) Dementia. Performance fell <10°percentile in memory, at least one other cognitive domain displayed <10°percentile performance; this low performance was considered the cause of impairment in previous functional level, and a confusion state was not present. 15 The Clinical Dementia Rating Scale (CDR) was used to document dementia severity. 16 Alzheimer's disease
Family Practice-an international journal (AD) and other dementia aetiologies were diagnosed according to the usual criteria. [17] [18] [19] All participants were scheduled for a follow-up visit after 1 year of baseline assessment. In this follow-up visit, neurological and mental status exam (including MMS), and CDR, were performed by the senior neurologist (JO); cognitive and psychiatric diagnoses were performed following the same criteria as at baseline visit, except that the neuropsychological battery was not administered. Throughout the study, laboratory determinations and other ancillary tests (e.g. cranial computed tomography scan) were performed as the clinical situation indicated.
Statistical analyses
Chi-square test, Mann-Whitney test, t-test and unadjusted analysis of variance were used to compare the clinical variables of the different groups of interest. The planned comparisons were NCI versus MCI versus dementia at baseline and MCI that progressed to dementia at 1-year follow-up versus MCI that did not progress. For all comparisons and analyses, patients within the 'non-relevant cognitive dysfunction' group were included in the NCI group. All statistic tests were two-tailed. Those variables displaying statistically significant differences or trends (P < 0.1) in unadjusted comparisons were then analysed by logistic regression models to establish the best predictors of the outcomes of interest. A stepwise procedure was used, with p-to-enter and p-to-leave values of <0.05 and >0.10, respectively. Age, sex and education were introduced as covariates in the regression models. Since this paper was focused on clinical variables different from cognitive testing, the regression analyses were performed not considering the MMS.
Results
Main study procedures, outcomes and patient disposition are displayed in Figure 1 . The PCP recruited 182 patients. Four patients declined to participate in the study and two patients were lost to follow-up; therefore, 176 patients will be described and analysed in this paper. A reliable informant was available for 167 of these patients (50.9% daughter or son, 33.0% spouse and 16.2% other) and formal neuropsychological evaluation could be performed in 169 patients.
Mean age was 72.1 years (SD 9.0; range 50-88); 77.8% of the patients were >65 years of age and most patients (70.5%) were women. The educational achievement was as follows: illiterate, 5.7%; none or incomplete primary education, 44.3%; primary school, 43.8%; superior education, 6.3%. It was a rather healthy sample: the mean number of chronic medical conditions was 2.2 (SD 1.6; range 0-7) and the mean number of medications was 2.7 (SD 2.1; range, 0-10). The following medical conditions were recorded in >20% of individuals: hypertension (40.0%), dyslipemia (29.7%) and osteoarthritis (23.6%). The most used medications were antihypertensive drugs (42.9%), anxiolytic or hypnotic agents (23.1%) and antiplatelet agents (21.7%).
Failure of recent memory was the most frequent cognitive manifestation (68.8%), followed by attention/dysexecutive (43.8%), behavioural (15.3%), affective (10.2%), language (9.1%) and visuospatial (2.3%) symptoms (39.8% of patients presented symptoms in more than one area). Symptoms were raised by patient (63.1%), informant (22.7%) and both (9.1%) or PCP (5.1%). Mean duration of symptoms was 2.5 years (SD 3.3; range 1 month to 20 years). A sudden onset was described in 13.6%, and some precipitating factor FIGURE 1 Study procedures, outcomes and patient disposition. NCI, no (or non-relevant) cognitive impairment; MCI, mild cognitive impairment; Dem, dementia was identified in 37.9% of the total patients. Some abnormality in the neurological exam was found in 28.8% and a psychiatric disorder was established in 25.3% of patients (it was a mood and/or anxiety disorder in virtually all the cases). Cognitive impairment of clinical relevance (i.e. MCI or dementia) was diagnosed in 99 (56.3%) patients at baseline (46.0% MCI, 7.4% mild dementia and 2.8% moderate dementia); non-relevant cognitive dysfunction was diagnosed in 10 (5.7%) patients and NCI was established in the remaining 67 (38.1%) individuals. Considering all the potential care-receivers and the whole recruiting period, these figures represented a detection rate of 2.4% for MCI or dementia (annual detection rate of 0.9%). The detection rate considering only people >65 years of age was 3.4% (annual detection rate of 1.3%). All the new cases of dementia were >65 years of age (mean age, 81.1; SD, 4.9; range 69-88). The annual detection rate of MCI in the people >65 years of age was 1.0%, whereas the annual detection rate of dementia in this age segment was 0.3%.
The cognitive diagnoses after 1 year were as follows: no (or non-relevant) cognitive impairment, 119 (67.6%) patients; MCI, 33 (18.8%); mild dementia, 19 (10.8%) and moderate dementia, 5 (2.8%) (Fig. 1) . Eight of 81 (9.9%) patients with MCI at baseline had progressed to dementia at 1-year follow-up visit. Two baseline dementia diagnoses did not persist at 1-year follow-up: one patient reverted to normal cognition (Lewy body dementia at baseline and psychiatric diagnosis at follow-up) and one patient reverted to MCI (vascular aetiology at both baseline and follow-up). The aetiology of dementia at 1-year follow-up assessment was probable AD, 16 (66.7%) patients; AD plus cerebrovascular disease, 4 (16.7%) and other dementia, 4 (16.7%). Of the 81 patients with MCI, 48 (59.3%) patients reverted to normal cognition at 1-year follow-up visit. This evolution was considered of particular relevance for primary care and therefore a post hoc comparison between those patients with MCI who reverted to normal cognition and those who remained impaired or progressed to dementia was performed.
Old age, source of symptoms (informant or PCP) and low score in the MMS were strongly associated with a poor cognitive diagnosis at baseline (Table 1) . When the prevalence of MCI or dementia at baseline and the prevalence of dementia after 1 year were depicted according to symptom source, a gradual increase in risk was observed from patient as only complainer (lowest risk) to informant as the only source of symptoms (highest risk) (Fig. 2) . Low formal education and presence of abnormal signs in the neurological exam were associated with MCI and dementia at baseline. In addition, the participants from the two cognitively impaired groups tended to present shorter symptom duration (P = 0.071) ( Table 1) . Attention/dysexecutive symptoms were more frequent in patients with MCI or normal cognition at baseline, and those patients also tended to refer some precipitating factor (P = 0.140). Of note, the four patients who had visuospatial symptoms were cognitively impaired at baseline (three patients MCI and one patient dementia) and all of them remained impaired 1 year later (two patients MCI, one patient mild dementia and one patient moderate dementia).
Age and family history of dementia were higher and MMS was lower in those MCI patients who converted to dementia when compared to those MCI patients who did not convert. MCI converters also tended to have less education achievement and lower frequency of attention/dysexecutive symptoms. Compared to those who did not revert, MCI patients who reverted to normal cognition were younger, associated less medical comorbidity, did not have visuospatial symptoms (trend) and tended to display affective symptoms more frequently (Table 1) .
Age, source, duration of symptoms and education predicted MCI or dementia at baseline in regression analysis ( Table 2 ). Low educational achievement strongly predicted conversion from MCI to dementia, while age only contributed marginally. Medical comorbidity and older age were associated to MCI that persisted or progressed to dementia, whereas affective symptoms tended to herald MCI reversibility ( Table 2 ).
Discussion
After 31 months of surveillance of cognitive impairment of unknown cause by PCP, 176 candidate patients were identified, of whom 46% had MCI and 10% had dementia. The observed annual detection rate of MCI (1.0%) was consistent with 0.9-1.4% annual incidence described in two previous community surveys. 20, 21 However, the annual rate of dementia detection (0.3%) was low compared to an estimated annual dementia incidence of 0.9% in Western Europe population. 22 Since most dementia patients (72%) displayed dementia of mild severity, this low diagnostic coverage could be due, at least in part, to new dementia cases that did not attend PCP consultation or were considered too ill for study participation.
We observed a rate of progression from MCI to dementia of 9.9% after 1 year, which is consistent with a rate of 9.6% observed in a recent meta-analysis of studies performed in specialized clinical settings. 8 As also well-known, age was strongly associated with dementia, 2 MCI and MCI progression to dementia. 23 In addition, we also demonstrated a role of (young) age in the prediction of MCI patients who reverted to normal cognition (Tables 1 and 2) .
The proportion of patients with MCI who reverted to normal cognition (59.3%) was high compared to previous studies conducted either in the population 20, 21 or
Family Practice-an international journal in the specialized clinical setting. 24 This result could be attributed to study limitations: a formal neuropsychological assessment was not performed at the follow-up visit, and the follow-up period of 1 year was short. However, a high reversion rate from MCI to normal cognition could also be interpreted as a genuine finding of primary care, where subjects looking for help due to social or psychological distress rather than because of true medical conditions, may be overrepresented. The presence of affective symptoms in those MCI patients who reverted to normal cognition supports this hypothesis (Tables 1 and 2 ). Hence, stressful situations or mild psychiatric conditions could have contributed to either false positive or genuine diagnosis of MCI in those patients who reverted. 25 We are expanding the present research to ascertain whether the diagnosis of MCI, made on the basis of PCP suspicion rather than on the basis of study of every complaint, displays more stability in time.
A majority of patients were women, although female sex tended to protect from cognitive impairment and dementia at baseline (Table 2 ). This finding, apparently inconsistent with the role of female sex as a risk factor of AD, 25 should be interpreted in light of the social and medical context of the study. In the traditional Spanish family, women did not work out of the house but assumed the stressing role of keeping the household and looking after family members. This condition, along with the opportunity of free medical consultation, explains why women could more frequently present cognitive complaints with normal performance. 26 We found a strong association between low educational level and MCI or dementia at baseline (Tables  1 and 2 ). The protective role of education was largely described in previous studies and has been interpreted in terms of brain (or cognitive) reserve. 27 In the present study, low education was also associated with an increased risk of conversion from MCI to dementia (Table 2) . Similar findings were reported in a previous community-based survey 28 but not in other study that was conducted in a university centre. 23 In both Scarmeas' 28 and the present study, people in the lowest strata of educational achievement were overrepresented.
The number of symptomatic domains was not related to cognitive diagnosis, although interesting associations or trends emerged when symptom profile was analysed (Table 1) . Attention/dysexecutive symptoms were more frequent in NCI and MCI groups and tended to be more frequent in those MCI subjects who did not progress to dementia. Cognitive dysfunction due to psychological distress is typically referred as attention lapses and cognitive dysfunction of nondegenerative aetiologies (e.g. vascular and medical conditions) is particularly associated with dysexecutive syndrome. 29 The opposite trend was observed for memory and visuospatial symptoms, which were more frequent in dementia patients and in those MCI patients who progressed to dementia (Table 1) . A higher risk dementia due to AD was reported in amnestic MCI; 23, 28 on the other hand, a higher risk of dementia in MCI patients who displayed visuospatial symptoms is consistent with AD dementia and, particularly, with Lewy body dementia. Hierarchical regression analysis: age, sex and education were first included in the models and then conditional analysis was performed for those variables that displayed differences or trends (P < 0.10)
in not adjusted comparisons (Table 1) . Source (of symptoms) was coded as 1 (patient only) or 2 (informant or PCP); sex was coded as 1 (man) or 2 (woman). Aff., affective; med. cond., chronic medical conditions; CI, confidence interval; OR, odds ratio.
FIGURE 2 Frequency of cognitive diagnoses by source of symptoms. P < .001 for the two cognitive diagnoses
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Source of symptoms and cognitive diagnosis were tightly associated, with the most accurate perception coming from family informant. When family informant, but not patient, was the source of symptoms, the frequency of MCI or dementia was 82.5% (Fig. 2) . Lack of insight was previously reported in MCI patients who converted to AD dementia 30 and, more recently, a family caregiver questionnaire was added to cognitive testing to detect patient candidates for further assessment. 31 As a novel contribution, we found a gradual increase in predictive value according to symptom source, with PCP falling between patient and family informant. The lack of adequate temporal perspective might have contributed to the inclusion of false positive cases by PCP, for whom there were no complaints by the patient or family informant. Overall, these results reinforce the value of family informant in the detection of cognitive deterioration.
This paper was aimed at exploring the value of a set of variables that are usually collected in the medical history of patients with suspected cognitive impairment and, in this regard, several new findings are worth highlighting. Short symptom duration was related to MCI or dementia at baseline (Table 2 ) and a trend of short symptom duration was found in those MCI patients who converted to dementia (Table 1) . Rather than exact timing from symptom onset, short symptom duration might represent the perception of more rapid deterioration. This is consistent with findings from longitudinal studies that showed acceleration of cognitive decline 1-3 years before dementia diagnosis. 32 Several other associations or trends deserve further investigation. The low number of medical conditions in those MCI patients who reverted to NCI was a novel finding that raises interesting questions about the relationship between systemic diseases and cognitive impairment (Tables 1 and 2 ). Sudden symptom onset and identification of a precipitating factor tended to be more frequently reported in patients with normal cognition, MCI and in those MCI patients who did not convert to dementia. Non-degenerative causes of cognitive symptoms, such as medical diseases, psychiatric conditions and cerebrovascular disease, could explain these trends. An abnormal neurological exam was associated with MCI and dementia in the unadjusted comparisons (Table 1) , possibly indicating vascular and Lewy body aetiologies. Unadjusted analyses also yielded a significant association between family history of dementia and increased risk of dementia conversion in MCI patients (Table 1 ). All these findings deserve further investigation in larger samples.
Apart from the small sample size, this study was limited by short follow-up that questions the findings related to MCI evolution. However, this study also had strengths. All non-test-derived clinical domains were prospectively and systematically recorded and some of them (e.g. symptom profile and course) were thoroughly typified. In addition, the diagnosis of cognitive impairment was performed independently by an expert, and very few cases were lost to follow-up. Hence, the rates of new MCI and dementia, and MCI outcomes, should be valid and representative of the care context where the study was conducted.
In conclusion, a clinical approach based on anamnesis and physical exam (i.e. medical history) is still mandatory and useful in the early detection and management of cognitive deterioration in primary care. Key features regarding symptom source, profile, course, medical and psychiatric co-morbidity, family history of dementia and neurological examination, should be systematically collected. Acting as 'rules of thumb', 33 old age, low education, cognitive deterioration according to informant and short symptom duration, should raise the level of suspicion and will help to optimize cognitive testing 34 and specialist referral.
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